A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer

BACKGROUND: While many of these agents have been compared in prospective clinical trials, the gemcitabine/platinumbased regimens have not been compared in a prospective, randomized clinical trial. While bothgemcitabine/carboplatin and gemcitabine/cisplatin have a similar ORR in separate clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Tran N., Harvey, Rachel E., Kim, Christine K., Brown, Jubilee, Coleman, Robert L., Smith, Judith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684736/
https://www.ncbi.nlm.nih.gov/pubmed/29158911
http://dx.doi.org/10.1186/s40661-017-0053-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684736/
https://www.ncbi.nlm.nih.gov/pubmed/29158911
http://dx.doi.org/10.1186/s40661-017-0053-x

Ejemplares similares